U.S. markets closed
  • S&P Futures

    4,155.50
    -9.25 (-0.22%)
     
  • Dow Futures

    33,968.00
    -48.00 (-0.14%)
     
  • Nasdaq Futures

    13,886.50
    -32.75 (-0.24%)
     
  • Russell 2000 Futures

    2,227.30
    -11.10 (-0.50%)
     
  • Crude Oil

    61.15
    -0.20 (-0.33%)
     
  • Gold

    1,793.90
    +0.80 (+0.04%)
     
  • Silver

    26.55
    -0.02 (-0.08%)
     
  • EUR/USD

    1.2041
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.5640
    +0.0020 (+0.13%)
     
  • Vix

    17.50
    -1.18 (-6.32%)
     
  • GBP/USD

    1.3933
    +0.0001 (+0.01%)
     
  • USD/JPY

    108.0160
    -0.0270 (-0.02%)
     
  • BTC-USD

    53,995.05
    -2,435.80 (-4.32%)
     
  • CMC Crypto 200

    1,244.49
    -18.47 (-1.46%)
     
  • FTSE 100

    6,895.29
    +35.42 (+0.52%)
     
  • Nikkei 225

    28,846.74
    +338.19 (+1.19%)
     

Company News for Feb 4, 2021

Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Shares of AbbVie Inc. ABBV gained 3.4% after the company reported fourth-quarter 2020 earnings of $2.92 per share, beating the Zacks Consensus Estimate of $2.85 per share.

  • Sony Corporation’s SNE shares soared 12.2% after it reported third-quarter fiscal 2020 earnings of $2.64, surpassing the Zacks Consensus Estimate of $0.80 per share.

  • Shares of Humana, Inc HUM gained 0.8% after the company reported fourth-quarter 2020 loss of $2.30 per share, narrower than the Zacks Consensus Estimate of a loss of $2.35.

  • The Scotts Miracle-Gro Company’s SMG shares jumped 5.1% after the company reported first-quarter 2021 earnings of $0.39 per share, beating the Zacks Consensus Estimate of a loss of $0.73 per share.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Sony Corporation (SNE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research